182 related articles for article (PubMed ID: 7853798)
61. Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects.
Losa M; Bock L; Schopohl J; Stalla GK; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1984 Dec; 107(4):462-70. PubMed ID: 6440392
[TBL] [Abstract][Full Text] [Related]
62. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Abe K
J Clin Endocrinol Metab; 1994 Mar; 78(3):509-12. PubMed ID: 8126120
[TBL] [Abstract][Full Text] [Related]
63. Growth hormone release in chickens after oral administration of thyrotropin releasing hormone.
Burke WH; Vaughters PD
Poult Sci; 1984 Nov; 63(11):2278-84. PubMed ID: 6440136
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of GH paradoxical responses to TRH and LHRH in acromegalic patients during long-term treatment with octreotide.
Merola B; Colao A; Cataldi M; Rossi E; Selleri A; Briganti F; Schettini G; Bellastella A; Lombardi G
Horm Res; 1992; 37(1-2):18-22. PubMed ID: 1398471
[TBL] [Abstract][Full Text] [Related]
65. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.
Chiodera P; Coiro V; Speroni G; Capretti L; Muzzetto P; Volpi R; Butturini U
J Clin Endocrinol Metab; 1984 Oct; 59(4):794-7. PubMed ID: 6434581
[TBL] [Abstract][Full Text] [Related]
66. The effect of thyrotropin-releasing hormone (TRH) and somatostatin (GHRIH) on growth hormone and prolactin secretion in vitro and in vivo in the domestic fowl (Gallus domesticus).
Harvey S; Scanes CG; Chadwick A; Bolton NJ
Neuroendocrinology; 1978; 26(4):249-60. PubMed ID: 98725
[TBL] [Abstract][Full Text] [Related]
67. Growth hormone response to a novel growth hormone-releasing tripeptide in horses: interaction with gonadotropin-releasing hormone, thyrotropin-releasing hormone, and sulpiride.
Kennedy SR; Thompson DL; Pruett HE; Burns PJ; Deghenghi R
J Anim Sci; 2002 Mar; 80(3):744-50. PubMed ID: 11890411
[TBL] [Abstract][Full Text] [Related]
68. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
69. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients.
Besarab A; Golper TA
ASAIO Trans; 1991; 37(3):M395-6. PubMed ID: 1751205
[TBL] [Abstract][Full Text] [Related]
70. Improvement of thyroid hormone profile and thyrotrophin (TSH) surge alterations in hemodialysis patients on erythropoietin treatment.
Utas C; Taskapan H; Oymak O; Akpolat T; Arinsoy T; Kelestimur F
Clin Nephrol; 2001 Jun; 55(6):471-6. PubMed ID: 11434359
[TBL] [Abstract][Full Text] [Related]
71. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
72. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
[TBL] [Abstract][Full Text] [Related]
73. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
74. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
Kagabu Y; Mishiba T; Okino T; Yanagisawa T
Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
[TBL] [Abstract][Full Text] [Related]
75. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
[TBL] [Abstract][Full Text] [Related]
76. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
[TBL] [Abstract][Full Text] [Related]
77. Anomalous growth hormone responses to thyrotropin-releasing hormone and glucose in cirrhotic patients: the effect of metergoline.
Salerno F; Cocchi D; Frigerio C; Colombo AM; Müller EE
J Clin Endocrinol Metab; 1980 Sep; 51(3):641-6. PubMed ID: 6773980
[TBL] [Abstract][Full Text] [Related]
78. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
Marek J; Límanová Z; Srámková J
Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
[TBL] [Abstract][Full Text] [Related]
79. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
80. Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.
De Marinis L; Mancini A; Zuppi P; Anile C; Maira G
Acta Endocrinol (Copenh); 1990 Apr; 122(4):443-9. PubMed ID: 2110409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
